Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 10Insulin Resistance 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Prostatic Neoplasms 4Diabetes Mellitus, Type 2 4Pancreatic Neoplasms 3Diabetes Mellitus 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Metabolic Syndrome 2Leukoplakia, Oral 2Leukemia, Myeloid, Chronic-Phase 2Inflammation 2Carotid Intimal Medial Thickness 1 2Breast Neoplasms 2Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene 1Sleep Apnea, Obstructive 1Skin Neoplasms 1Recurrence 1Prostatic Neoplasms, Castration-Resistant 1Pharmacokinetics of MDV3100 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Meningioma 1Memory Disorders 1Lung Neoplasms 1Liposarcoma, Myxoid 1Liposarcoma 1Leukemia, Myeloid, Acute 1

Interventions

relacorilant 5Metformin 5Pioglitazone 4Dipeptidyl-Peptidase IV Inhibitors 4Sulfonylurea Compounds 3Sitagliptin Phosphate 3Resistance Training 3saxagliptin 2Vildagliptin 2Sodium-Glucose Transporter 2 Inhibitors 2Rosiglitazone 2Nutritional Status 2Glucagon-Like Peptide-1 Receptor Agonists 2Blood Specimen Collection 2voglibose 1somapacitan 1semaglutide 1repaglinide 1pembrolizumab 1miglitol 1metahexamide 1meglitinide 1mazdutide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1empagliflozin 1desaminopancreozymin octapeptide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Diabetes Mellitus, Type 2 × Pioglitazone × Clear all
NCT05098327 2023-08-15

Pioglitazone and Insulin Resistance in ADT

State University of New York at Buffalo

Phase 3 Withdrawn
Genitourinary

Diabetes Mellitus, Type 2, Insulin Resistance, Prostatic Neoplasms

NCT01935466 2022-01-25

PROBE-PIO

Post Graduate Institute of Medical Education and Research, Chandigarh

Completed
6,107 enrolled
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus, Type 2

NCT02475499 2016-03-14

Incretin-based Drugs and Pancreatic Cancer

Canadian Network for Observational Drug Effect Studies, CNODES

Completed
886,172 enrolled
Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT01223196 2016-01-11

PIO-TACE

The University of Texas Health Science Center at San Antonio

Phase 4 Completed
60 enrolled 8 charts

Diabetes Mellitus, Type 2, Insulin Resistance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡